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Being responsible for delayed wound healing, the presence of biofilms in infected wounds leads to chronic, and
difficult to treat infections. One of the reasons why antimicrobial treatment often fails to cure biofilm infections is
the reduced penetration rate of antibiotics through dense biofilms. Strategies that have the ability to somehow
interfere with the integrity of biofilms and allowing a better penetration of drugs are highly sought after. A
promising new approach is the use of laser-induced vapor nanobubbles (VNB), of which it was recently
demonstrated that it can substantially enhance the penetration of antibiotics into biofilms, resulting in a marked
improvement of the killing efficiency. In this study, we examined if treatment of biofilms with laser-induced vapor
nanobubbles (VNB) can enhance the potency of antimicrobials which are commonly used to treat wound in-
fections, including povidone-iodine, chlorhexidine, benzalkonium chloride, cetrimonium bromide and mupirocin.
Our investigations were performed on Pseudomonas aeruginosa and Staphylococcus aureus biofilms, which are often
implicated in chronic wound infections. Pre-treatment of biofilms with laser-induced VNB did enhance the killing
efficiency of those antimicrobials which experience a diffusion barrier in the biofilms, while this was not the case
for those compounds for which there is no diffusion barrier. The magnitude of the enhanced potency was in most
cases similar to the enhancement that was obtained when the biofilms were completely disrupted by vortexing
and sonication. These results show that laser-induced VNB are indeed a very efficient way to enhance drug
penetration deep into biofilms, and pave the way towards clinical translation of this novel approach for treatment
of wound infections.Introduction
Chronic wounds such as diabetes wounds, pressure ulcers, and venous
ulcers, affect a substantial fraction of the world population [1]. It is
estimated that in the United States alone, 6.5 million people suffer from
chronic wounds [2]. Due to increasing health care costs, aging population
and epidemic rise of obese and diabetic people, the burden of chronic
wounds to the healthcare system is believed to increase even further in
the nearby future [1]. Bacterial infections can significantly delay wound
healing [3] and microbial biofilms are increasingly recognized as an
important reason for treatment failure [4,5]. Therefore, it is important to
direct wound care towards diagnosis and eradication of these biofilms iniochemistry and Physical Pharma
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is an open access article under torder to achieve better clinical outcomes [6].
The biofilm lifestyle offers protection to bacterial cells against anti-
microbials due to a complex interplay of multiple factors, including
reduced metabolic activity, heterogeneity of microenvironments, pres-
ence of persister cells and reduced penetration of antimicrobials [7,8]. In
the present study we focus on the latter problem, which is commonly
referred to as the biofilm diffusion barrier. On the one hand it is caused
by physicochemical interactions that can occur between antibiotics and
biofilm constituents such as polysaccharides, extracellular DNA or en-
zymes, all of which can inactivate or slow down the diffusion of anti-
microbial agents. On the other hand, hindered penetration also stems
from the fact that sessile cells are packed tightly together in densecy, University of Ghent, Ghent, 9000, Belgium.
ent.be (K. Braeckmans).
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Fig. 1. Schematic overview of the experimental pro-
tocol. Biofilms are loaded with small cationic AuNP
and irradiated with pulsed laser light in order to
create vapor nanobubbles (VNB) inside the bacterial
cell clusters. Besides VNB-formation, biofilms were
also disrupted mechanically by means of vortex/son-
ication as a positive control. Then, a broad panel of
antimicrobials frequently used in wound treatment
were added to the treated biofilms, and it was evalu-
ated to which extent their efficacy was improved.
E. Teirlinck et al. Biofilm 1 (2019) 100004microcolonies of tens to hundreds of micrometers in size [9–13]. Even
though most drug molecules are small enough to diffuse through the
spaces between cells, the net flux towards deeper cell layers is reduced
since they all have to pass through those narrow openings. Therefore,
innovative strategies that can somehow interfere with the dense structure
of biofilms to enhance drug penetration of current interest, including for
wound care [14].
One approach is to make use of anti-biofilm agents, for instance
enzymatic approaches like the use of dispersin B that has been shown to
degrade critical components of the extracellular polymeric substances
(EPS) matrix of methicillin resistant S. aureus in a chronic wound mouse
model [15,16]. Quorum sensing inhibitors are another example of agents
that can interfere with bacterial communication that regulates biofilm
formation in chronic wounds [17,18]. However, broad applicability of
such pharmacological approaches is limited as they target very specific
components of the biofilm. Physical methods on the other hand may be
more flexible as their mechanism typically does not depend on the spe-
cific composition of a biofilm. Along these lines we have recently re-
ported on a new approach that is based on the combination of
nanotechnology and laser treatment to locally disturb biofilm integrity,
improving the penetration and effectiveness of antibiotics [19]. In this
approach biofilms are first incubated with small gold nanoparticles that
have the ability to penetrate deep into biofilms (Fig. 1). Such gold
nanoparticles can absorb the energy of high-intensity, short laser pulses,
causing their temperature to rise to several hundreds of degrees within
nanoseconds. The water surrounding the particles then quickly evapo-
rates, resulting in expanding and imploding water vapor nanobubbles
(VNB) [20,21]. The generated pressure waves can locally disturb the
organization of tightly packed sessile cells, allowing better penetration of
drug molecules deep into the biofilm. It was found that pretreatment of
biofilms with VNB substantially improved the efficacy (up to 3000-fold)
of the antibiotic tobramycin in biofilms formed by Pseudomonas aerugi-
nosa and Staphylococcus aureus [19].
Excellent spatial control is another important advantage of using VNB
to disrupt wound biofilms. Indeed, as laser light can be perfectly
controlled in time and space, unwanted side effects like tissue damage
are likely to be reduced to a minimum. Furthermore, VNB-formation only
causes biofilm deformation at the location of the exploding nanobubbles
without causing the bacteria to be released into the surrounding medium.
This is an important consideration when translating this concept to the2
clinic with minimal risk for systemic spread and sepsis [22]. Another
important feature of laser-induced VNB is that, contrary to ultrasound
treatment, net transfer of heat to the surrounding healthy tissue is
avoided, as all the heat within the AuNP is efficiently converted into
mechanical energy [23].
In the present study, we investigated the use of laser-induced VNB for
the treatment of P. aeruginosa and S. aureus biofilms, which are often
found in infected wounds. Its potential to enhance the efficacy of a broad
range of commercially available wound products was tested, including
povidone-iodine (Pvp-I), chlorhexidine (Chx), benzalkonium chloride
(BzCl), cetrimonium bromide (Cetr) and mupirocin (Mupi). We
compared the antimicrobial activity after VNB treatment with the ac-
tivity against undisturbed biofilms and biofilms that were completely
disrupted by vortexing and ultrasound treatment. Our results showed
that VNB treatment enhanced the antimicrobial effect of the tested
compounds to the same level as forced disruption by sonication and
vortexing, clearly demonstrating that laser-induced VNB are an effective
way to overcome the diffusion barrier. A potentiating effect was found
for BzCl (~21x) in P. aeruginosa biofilms, and Cetr (~24x) and Mupi
(~53x) in S. aureus biofilms, which could even be increased to a complete
loss of survival after repeated VNB-formation in case of Mupi. Instead, for
the other tested combinations, such as Pvp-I, Chx and Cetr in P. aerugi-
nosa biofilms and BzCl in S. aureus biofilms, it turned out that there was
no diffusion barrier. Together our results highlight the importance of the
diffusion barrier in biofilms, and the potential of laser-induced VNB to
enhance the efficacy of those antimicrobials which suffer from a diffusion
barrier in biofilms.
Results
Combining VNB treatment and disinfectants in P. aeruginosa biofilms
The effect of VNB treatment on the efficacy of various wound-related
disinfectants was first evaluated on P. aeruginosa biofilms, as this is an
important pathogen often found in biofilm-infected wounds [24].
Cationic 70 nm AuNP (which were previously shown to be able to
penetrate P. aeruginosa biofilms [19]) were added to the biofilms, and
biofilms were subsequently illuminated with pulsed laser light (7 ns,
561 nm). The laser beam had a diameter of approximately 150 μm and
was scanned across the biofilm so that each location received 1 or
Fig. 2. Vapor nanobubble mediated biofilm disrup-
tion in P. aeruginosa (upper panel) and S. aureus
(lower panel) biofilms. Dark field images were taken
before, during and immediately after VNB generation
by a single nanosecond laser pulse of 561 nm at a laser
fluence of 1.7 J cm2. The location of the laser pulse is
indicated by a yellow circle. The red arrow heads
point towards the location of vapor nanobubbles
which are visible as small bright spots due to
increased light scattering during their lifetime. Scale
bar¼ 100 μm. (For interpretation of the references to
colour in this figure legend, the reader is referred to
the Web version of this article.)
Fig. 3. Anti-biofilm effect of pre-treatment with
VNB and subsequent addition of various wound-
related disinfectants on P. aeruginosa biofilms: (a)
povidone-iodine (Pvp-I), (b) chlorhexidine (Chx),
(c) benzalkonium chloride (BzCl), (d) cetrimonium
bromide (Cetr). CTRL: 0.9% NaCl solution, AuNP þ
disinfectant: addition of AuNP with subsequent
disinfectant treatment, Laser þ disinfectant: laser
control (without AuNP) and subsequent disinfectant
treatment, VNB þ disinfectant: laser-induced VNB
treatment followed by the addition of disinfectant,
Disruption þ disinfectant: complete biofilm disrup-
tion by vortexing/sonication and subsequent disin-
fectant treatment. Each anti-biofilm effect was
tested in at least 3 biological repeats and each bio-
logical repeat consisted of 3 technical repeats
(n 3 3) (p< 0.05).
E. Teirlinck et al. Biofilm 1 (2019) 100004maximum 2 laser pulses (there is a certain overlap between consecutive
pulses to ensure that each location of the biofilm receives at least one
pulse). Laser pulses were applied with a fluence of 1.7 J cm2, which is
well above the VNB fluence threshold of 70 nm AuNP in water [19], so
that VNB were effectively formed. As shown in Fig. 2, dark field micro-
scopy confirmed that VNB were formed, which generally resulted in a3
visible alteration of the morphology of the cell clusters.
After laser irradiation, the biofilms were treated for 5min with either
Pvp-I, Chx, BzCl or Cetr at concentrations of 0.01%, 0.04%, 0.06% or
0.15% (w/v) respectively. Cell survival was quantified by plate counting
after addition of neutralizing broth. In case of Pvp-I, treating P. aeruginosa
biofilms by VNB did not result in an enhanced efficacy of the disinfectant
Fig. 4. Anti-biofilm effect of pre-treatment
by laser-induced VNB followed by the
addition of (a) benzalkonium chloride
(BzCl), (b) cetrimonium bromide (Cetr) or
(c) the antibiotic mupirocin (Mupi) in S.
aureus biofilms. CTRL: 0.9% NaCl solution,
AuNP þ antimicrobial agent: addition of
AuNP with subsequent antimicrobial agent
treatment, Laser þ antimicrobial agent:
laser and subsequent antimicrobial agent
treatment, VNB þ antimicrobial agent:
laser-induced VNB treatment followed by
the addition of the antimicrobial agent,
Disruption þ antimicrobial agent: complete
biofilm disruption by vortexing/sonication
and antimicrobial agent treatment, Disrup-
tion þ AuNP þ Mupi: complete biofilm
disruption in presence of AuNP and subse-
quent mupirocin treatment. Each anti-
biofilm effect was tested in at least 3
biological repeats and each biological
repeat consisted of 3 technical repeats
(n 3 3) (p< 0.05).
E. Teirlinck et al. Biofilm 1 (2019) 100004(Fig. 3 a). A similar effect was seen for Chx, where no significant dif-
ferences were found between the survival of Chx treated or VNB þ Chx
treated P. aeruginosa sessile cells (Fig. 3 b). When P. aeruginosa biofilms
were treated with BzCl, however, a ~21 x increased effect of BzCl was
observed after VNB formation compared to BzCl treatment alone
(p¼ 0.03) (Fig. 3 c). This enhanced activity was only observed after
formation of VNB, as the controls of BzCl with AuNP (no laser) or BzCl
with laser (no AuNP) had no additional effect compared to BzCl treat-
ment. Finally, when P. aeruginosa biofilms were treated with Cetr, which,
like BzCl, is a quaternary ammonium compound, no significant addi-
tional effect of VNB pre-treatment was found in P. aeruginosa biofilms
(p¼ 1) (Fig. 3 d). It is important to note that we showed previously that
the generation of VNB by itself does not significantly affect the bacterial
viability of both P. aeruginosa as S. aureus biofilms under exactly the same
conditions [19]. The observed effects on the efficacies of the antimicro-
bial agents are thus solely attributed to the secondary effects of VNB
generation on the biofilm structure and not a direct effect of VNB
mediated killing of sessile cells.
In view of the positive results we obtained previously with P. aeru-
ginosa biofilms and the antibiotic tobramycin [19], it was at first sur-
prising that only 1 out of 4 tested disinfectants gave an additional effect
after VNB treatment. This led us to believe that very likely there is only a
diffusion barrier for BzCl, but not for the other three disinfectants in P.
aeruginosa biofilms. In order to verify this hypothesis, we performed a
positive control where biofilms were completely disrupted by 2 rounds of
vortexing and sonication before treatment with the same disinfectants.4
As can be seen in Fig. 3, apart from Cetr these forced disruption experi-
ments correlated well with the VNB results. Fig. 3 a and 3 b confirmed
that the efficacy of Pvp-I and Chx could not be enhanced by disrupting
the biofilm, indicating that there is no substantial diffusion barrier for
those compounds in P. aeruginosa biofilms. For BzCl on the other hand, a
~21 x reduction was observed in the amount of surviving cells, corre-
sponding remarkably well with the VNB results. Only for Cetr there was a
mismatch with the VNB results. As shown in Fig. 3 d, a ~12 fold
enhanced activity of Cetr was seen in the positive control, while this was
not the case after VNB treatment. This could be due to the fact that
forming VNB 1x only was insufficient to improve Cetr diffusion. Indeed,
in previous research [19] we already showed that repeated VNB forma-
tion could in some cases further enhance drug penetration. Therefore, we
repeated the laser treatment 5 times before adding Cetr, but as shown in
Fig. 3 d, no further enhancement of Cetr was obtained by repeated VNB
formation. Somewhat surprisingly, there was a significant 5-fold increase
in the amount of surviving cells after 5x VNB þ Cetr treatment compared
to only adding Cetr to P. aeruginosa biofilms. However, since we did not
observe such trends for the other antimicrobial agents and bacterial
biofilms, we believe that, in spite of being statistically different, its bio-
logical relevance is disputable.Combining VNB treatment with disinfectants and mupirocin in S. aureus
biofilms
We continued our studies on gram-positive S. aureus as another
E. Teirlinck et al. Biofilm 1 (2019) 100004pathogen that is often dominating wound-associated biofilms [24].
Because the forced disruption of P. aeruginosa biofilms suggested that
there is no diffusion barrier for Pvp-I and Chx, we excluded these disin-
fectants from the testing panel, and continued our study with BzCl and
Cetr – for which we did see an enhancement of their efficacy after dis-
rupting the biofilms – and evaluated their potential in combination with
VNB in S. aureus biofilms. In addition, the use of quaternary ammonium
derivates in the treatment of S. aureus infections is of interest since
Gram-positive bacteria tend to be more susceptible towards such
membrane-targeting agents due to their more vulnerable cell wall
compared to Gram-negative bacteria [25]. Next to BzCl and Cetr, we also
investigated the effect of VNB treatment in combination with mupirocin
(Mupi), an antibiotic often used to treat skin and soft tissue MRSA in-
fections [26,27]. The formation of VNB again resulted in a visible
deformation of S. aureus cell clusters, as shown in Fig. 2. In this case the
activity of BzCl was not enhanced after VNB treatment (Fig. 4 a), while a
~24 fold increased killing was seen with Cetr (Fig. 4 b). Importantly, this
enhanced effect of Cetr was only observed in combination with VNB, but
not with AuNP (p ¼ 0.61) or laser treatment only (p ¼ 0.51). For
mupirocin, it was noted that the combination with AuNP alone (AuNP þ
Mupi) already resulted in a ~3 times lower cell survival (Fig. 4 c), a
somewhat surprising finding as it was not observed for any of the other
tested compounds. Importantly, however, an extra ~53 times enhance-
ment of mupirocin was seen after VNB-formation.
Againwe found a good correspondence between these VNB results and
positive controlswhere the biofilmwas completely disruptedby vortexing
and sonication. ForBzCl indeedno significantly increasedeffectwas found
on disrupted biofilms, indicating that this compound does not experience
a diffusion barrier in S. aureus biofilms. The activity of Cetr on the other
hand increased~39 times on disrupted biofilms, similar towhatwe found
for VNB. In case of mupirocin, the disrupted biofilms were treated with a
combination of AuNP andmupirocin due to the abovementioned effect of
AuNP on this compound. In this case a ~250 fold enhanced activity was
found ofmupirocin on disrupted S. aureus biofilms. This is evenmore than
what was obtained with VNB, indicating that treatment of the S. aureus
biofilms with one laser pulse as we did so far may not have completely
resolved the diffusion barrier for mupirocin. Indeed, when the laser
treatment was repeated 5x on S. aureus biofilms, none of the cells survived
following the addition of mupirocin (Fig. 4 c).
Discussion
In the past decade, the clinical impact of biofilms in chronic wounds
has been increasingly recognized. One of the reasons why biofilm for-
mation decreases the effectiveness of antimicrobial treatment is because
of hindered diffusion of antimicrobials through biofilms. Indeed, several
studies reported on reduced diffusion of disinfectants through wound
biofilms, likely due to interaction with the extracellular polymeric sub-
stance (EPS) matrix [28,29]. For instance, De Beer et al. followed chlo-
rine penetration in mixed biofilms of P. aeruginosa and Klebsiella
pneumoniae by measuring chlorine concentrations with microelectrodes,
finding that the chlorine concentration inside the clusters was only 20%
of that of the incubating solution [30]. Reaction-diffusion interaction
with biofilm constituents was found to be responsible for the hindered
diffusion [31,32]. As another example, Ganeshnarayan et al. showed that
biofilm diffusion of the quaternary ammonium derivative cetylpyr-
idinium chloride was slowed down by electrostatic interactions with
poly-N-acetylglucosamine matrix polysaccharides [33].
In order to improve drug diffusion, a plethora of anti-biofilm agents
have been investigated for this purpose, such as enzymes and amino
acids, targeting specific components of the extracellular polymeric sub-
stance (EPS) matrix, or molecules that target pathways involved in bio-
film disruption such as the cyclic-di-GMP pathway, quorum sensing and
others [34,35]. Fleming et al. showed that the addition of glycoside hy-
drolase to mature P. aeruginosa and S. aureus wound biofilms degraded
EPS polysaccharides which increased the efficiency of subsequent5
antibiotic treatment [36]. In another study, Sanchez et al. reported on the
potential of D-amino acids to disrupt mature biofilms of P. aeruginosa and
S. aureus clinical wound isolates, thereby increasing the effectiveness of
several antimicrobial agents [37]. However, despite promising results in
vitro, clinical translation of these molecular disruption agents may be
hampered because of several reasons. First, off-target side effects can
occur since many of those targets are not only found in bacteria but in
human tissues as well [34]. Second, the highly variable nature of the EPS
composition that depends on the type of organism, substrate and host
interactions [28], combined with the fact that biofilm signaling mole-
cules are species and even strain dependent, add another level of
complexity that restricts the broad applicability of such approaches [38].
Third, as some agents rely on cellular processes such as interference with
cyclic-di-GMP and iron metabolism, cells have to be metabolically active
in order to be affected which is not always the case [28]. Lastly, although
it was previously accepted that these anti-biofilm agents targeted against
the biofilm should be less prone to drive resistance in contrast to classic
antimicrobial agents [34], a recent study indicated that this is not always
the case, as shown for the quorum sensing inhibitor baicalin hydrate in
Burkholderia cenocepacia biofilms [39].
Due to these shortcomings, rather than a pharmacological approach,
it is attractive to explore physical methods to interfere with the biofilm
integrity. Physical forces are largely independent of the bacterial
microflora and matrix composition, making them likely more universally
applicable. Currently, the gold standard for physically disrupting and
removing biofilms in wound beds is still repeated sharp debridement [34,
40]. However, as debridement is often painful and imprecise in removing
biofilms, there is an interest in newer and more refined methods [35,40].
While electric currents have been proven successful as anti-biofilm
strategy and reportedly may also promote wound healing, clinical
translation of this method is hampered because of heating of the sur-
rounding tissue and cytotoxicity [28]. Similarly, several studies reported
on ultrasound-mediated wound biofilm disruption in vitro, and its po-
tential to decrease exudate, slough and patient pain [41]. Another
experimental approach is the use of laser-generated shockwaves which
have been shown to disrupt S. epidermidis biofilms grown on pig skin
[42]. In this technique, metal coated surfaces were placed in close
proximity of biofilms and irradiated with laser light, which consequently
created shockwaves by means of laser-assisted ablation of metal films.
For both ultrasound as laser-generated shock wave therapy, further
studies are needed to assess their efficacy and rule out possible detri-
mental damage such as heating and off-target side effects in a clinical
setting [28,43]. Recently we presented the use of laser-induced VNB as a
new and refined approach to interfere with the biofilm structure to
enhance drug diffusion and efficacy [19]. A particular advantage of this
technique is that it can be applied locally with a high spatial control [44,
45]. Combined with the fact that it is not associated with heating effects
[23], it is expected to minimize off-target effects to the surrounding
healthy tissue. Furthermore, since the VNB shockwaves are produced
locally on a nano- and microscale from AuNP within the biofilm, it does
not cause bacteria to become spread in the environment, as previously
demonstrated [19]. Hence it minimizes the risk of recolonization of
disrupted bacteria, which could lead to biofilm formation in other loca-
tions of the human body and even life-threatening sepsis [34,46]. Lastly,
it is of note that the application of lasers in dermatology has increased
dramatically in recent years, and they have been used safely and effec-
tively in a wide variety of treatments, including vascular and pigmented
lesions, tattoos, scars, and psoriasis [47]. In the present study, we spe-
cifically investigated the potential of treating biofilms with laser-induced
VNB in the context of wound infections. In particular, we investigated the
potentiating effect of VNB treatment on antimicrobial agents that are
commonly used to treat infected wounds. Since VNB treatment enhances
drug diffusion, we also included positive controls where the biofilms
were completely disrupted by 2 rounds of vortexing and sonication as a
benchmark for the maximum achievable effect. This is a similar approach
as reported by Leung et al. who mechanically disrupted biofilms by
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biofilms to antimicrobial agents as compared to intact biofilms [48].
Treatment of P. aeruginosa biofilms with VNB did not increase the effi-
cacy of Pvp-I, Chx and Cetr, while the activity of BzCl was enhanced
21-fold. Similar results were found on disrupted biofilms, the only
exception being Cetr for which a small but significant effect was
observed. These results show that Pvp-I and Chx do not experience a
diffusion barrier in P. aeruginosa biofilms. For Pvp-I this was not that
surprising as it is known to be able to penetrate biofilms, which con-
tributes to its frequent use as antiseptic for wound treatment [49,50]. We
did, however, expect to find hindered diffusion for Chx as it is a highly
positively charged molecule which might get sequestered by negatively
charged matrix components (similar to e.g. tobramycin [51]). Looking
into literature, contradicting findings have been reported regarding
Chx’s penetration through biofilms. Some studies report on
EPS-mediated retardation of Chx diffusion [52–55], while others state
that Chx penetration is not an issue [56,57], which is more in line with
our findings. For BzCl on the other hand, we did find hindered diffusion
in P. aeruginosa biofilms, which could be due to its positively charged
quaternary ammonium head group and long alkyl tail. Indeed, it has been
proposed that for quaternary ammonium compounds, charged in-
teractions between negatively charged matrix components and cationic
ammonium groups on the one hand and hydrophobic interactions with
alkyl chains on the other hand play an important role in their affinity
towards biofilm matrices [58,59]. Hindered BzCl penetration through P.
aeruginosa biofilms was also observed in the study of Bridier et al., who
visualized the spatiotemporal pattern of BzCl-penetration and inactiva-
tion of P. aeruginosa biofilms by confocal laser scanningmicroscopy. They
found that, initially, BzCl only affected cells in peripheral layers of the
biofilm clusters, whereas cells located in the center of the clusters became
gradually inactivated during the course of the disinfectant treatment
[60]. Surprisingly, however, when the structurally similar quaternary
ammonium compound Cetr was tested, no significantly enhanced activity
was seen after VNB pre-treatment of P. aeruginosa biofilms, while its
activity increased by 12 times in disrupted biofilms. While the exact
reason for this difference is not clear, it suggests that when P. aeruginosa
biofilms are subjected to vortexing/sonication, some pathways become
affected that play a role in the protection against Cetr, which are not
affected by VNB-mediated disruption. Indeed, it has been reported before
that the way in which disruption is induced can affect the susceptibility
of disrupted cells against antimicrobials. For instance, in the study of
Chambers et al. it was shown that the susceptibility phenotype of dis-
rupted P. aeruginosa cells to antimicrobials differed between glutamate
and nitric oxide-mediated disruption, showing that different types of
disruption agents can result in disrupted cells with different antimicro-
bial sensitivity phenotypes [61].
When the activity of BzCl and Cetr was tested in S. aureus, it became
clear that biofilm penetration is not only molecule- but also biofilm-
dependent. Contrary to P. aeruginosa biofilms, BzCl had no additional
effect on VNB pre-treated S. aureus biofilms. The same was found on
disrupted S. aureus biofilms, showing that for BzCl there is no diffusion
barrier in these biofilms. Our results are in line with the study of Cam-
panac et al. [62] where disruption of S. aureus biofilms also did not
restore their sensitivity towards BzCl. Also for Cetr the opposite trend
was found in S. aureus biofilms, with a 24x enhanced activity in VNB
pre-treated biofilms, which could be confirmed in disrupted biofilms.
This emphasizes that biofilm diffusion studies cannot be generalized but
depend on the specific combination of microbial species and antimicro-
bial agent. When testing mupirocin on S. aureus biofilms, finally,
pre-treatment with VNB enhanced its killing efficiency by 53 times, with
even complete eradication when laser irradiation was 5x repeated. This
corresponded well to the 250 times enhancement that we found on
completely disrupted S. aureus biofilms, confirming the presence of a
strong diffusion barrier for mupirocin in S. aureus biofilms.
Although our study clearly demonstrates that VNB treatment of bio-
films can enhance the efficacy of several relevant antimicrobials that6
suffer from a diffusion barrier in a particular type of biofilm, we believe
that the importance of this type of novel treatment will become even
more convincing in more complex in vivo situations. The reasoning for
this is that biofilms residing in clinical wounds have a more complex
structure and EPS matrix compared to in vitro grown biofilms in 96-well
plates. Thus, the contribution of impaired mass transport, and hence the
potential of VNB to resolve this problem, is expected to be even more
important in mature wound biofilms. Therefore, it will be of interest to
evaluate this concept in more complex biofilm wound models integrating
different aspects of the wound environment, such as the presence of
plasma proteins, keratinocytes, and host immune responses [63,64]. As
dynamic interactions between multiple species play an important role in
the persistence of chronic wounds, it is also of interest to evaluate
whether VNB treatment has the same positive effect on multispecies
biofilms rather than simple monospecies communities.
Conclusion
Disrupting P. aeruginosa or S. aureus wound biofilms by laser-induced
VNB is a promising route to enhance the efficiency of antimicrobial
agents that experience hindered diffusion in biofilm-related wound in-
fections. Forced disruption experiments generally offered a good pre-
diction of the extent of improvement that is attainable with VNB pre-
treatment. Even though further work is needed to evaluate this novel
concept on more complex biofilm wound models and in vivo, these
promising results show the potential of laser-induced VNB to help
combating tenacious biofilm implicated wound infections.
Materials and methods
Materials and strains
P. aeruginosa LESB58 (LMG 27622) and S. aureus Mu50 were used.
Lysogeny Agar/Broth and Dey-Engley Neutralizing Broth (DENB) were
purchased from Lab M Limited (Lancashire, UK). Simulated wound fluid
(1:1 fetal bovine serum: 0.9% NaCl (w/v) in 0.1% peptone) was prepared
in-house. Fetal bovine serum was purchased from HyClone (Pierce,
Rockford, IL, USA), NaCl was obtained from Applichem (Darmstadt,
Germany) and peptone from BD Diagnostics (New Jersey, USA). AuNP
were purchased from Nanopartz (Loveland, USA) and were diluted in
ultrapure water prior to use. Poly(vinylpyrrolidone)-Iodine (Pvp-I),
chlorhexidine digluconate (20% in water) (Chx), benzalkonium chloride
(BzCl) and hexadecyltrimethylammonium bromide (Cetr) were pur-
chased from Sigma-Aldrich (Saint Louis, MO, USA). Mupirocin was ob-
tained from Toronto Research Chemicals (Toronto, Canada).
Biofilm formation
Biofilms were grown aerobically in 96-well SensoPlates (Greiner Bio-
One, USA) with microscopy grade borosilicate glass bottom for 24 h at
37 C. Biofilms of P. aeruginosa were grown in Lysogeny Broth, while S.
aureus biofilms were grown in simulated wound fluid, which was found
to be necessary in order for thick biofilms to be formed. The wells of the
96-well SensoPlate were filled with 100 μL of the bacterial suspension,
and incubated at 37 C. After 4 h, the adhered cells were washed with
physiological saline (0.9% NaCl (w/v)), covered with medium and
incubated for another 20 h at 37 C.
Formation and visualization of VNB inside biofilms
After 24 h of growth, the supernatant was removed and 100 μL of an
aqueous dispersion of AuNP (1.4Eþ10 AuNP mL1) was added to the
biofilm. To allow complete penetration, the biofilms were incubated for
15min at room temperature. Next, the supernatant was removed and
100 μL physiological saline was added to each well. A home-made optical
set-up was used to generate VNBs inside the biofilms, as previously
Table 1
Concentrations and contact times of the antimicrobial agents used in this study.
P. aeruginosa S. aureus
Concentration (w/v) Contact time CFU/biofilm CTRL Concentration (w/v) Contact time CFU/biofilm CTRL
Pvp-I 0.01% 5min 1.6 10̂7 
8.3 10̂6
x x x
Chx 0.04% 5min 1.8 10̂7 
1.2 10̂7
x x x
BzCl 0.06% 5min 1.6 10̂7 
8.2 10̂6
0.06% 5min 5.8 10̂6 
3.9 10̂6
Cetr 0.15% 5min 1.8 10̂7 
8.6 10̂6
0.15% 5min 1.8 10̂6 
9.1 10̂5
Mupi x x x 0.01% 24 h 4.1 10̂6 
3.7 10̂6
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epi-fluorescence microscope (Nikon, Nikon BeLux, Brussels, Belgium)
equipped with a Plan Fluor 10 0.3 NA objective lens (Nikon). An Op-
tical Parametric Oscillator (OPO) laser (OpoletteTMHE 355 LD, OPOTEK
Inc., Faraday Ave, CA, USA) produces laser pulses of 7 ns tuned to 561 nm
in order to excite the localized surface plasmon resonance of the AuNP
while at the same time being compatible with optical filters in the set-up.
The energy of each laser pulse is monitored with an energy meter
(J-25MB-HE&LE, Energy Max-USB/RS sensors, Coherent) synchronized
with the pulsed laser. In this study, a laser pulse fluence of 1.7 J cm2 was
used (calculated as the pulse energy of a single laser pulse divided by the
laser beam area (150 μm diameter)).
VNB formation was visualized by dark-field images before, during
and immediately after irradiation with a laser pulse, based on the light
scattering properties of VNB. The camera (EMCCD camera, Cascade
II:512, Photometrics, Tucson, USA) was synchronized with the pulsed
laser by an electronic pulse generator (BNC575, Berkeley Nucleonics
Corporation, CA, USA) to compensate for the short nature of VNB gen-
eration (lifetime< 1 μs). For dark field imaging, the biofilms were
cultured 24 h at 37 C in 50mm glass bottom dishes (No. 1.5 coverslip)
(MatTek Corporation, Ashland, USA).
Disinfection procedures
After laser treatment, 100 μL supernatantwas removedand thebiofilm
was covered with 120 μL of disinfectant, antibiotic or control solution
(0.9% NaCl (w/v)), as displayed in Table 1. Concentrations and contact
timeswere chosen to achieve a suboptimal killing of the sessile cells. After
the prescribed contact time, the disinfectants were neutralized by adding
80 μL of 2.5x concentrated DENB. After 5min neutralization time, 200 μL
supernatant was removed and the sessile cells were washed with physio-
logical saline. In case ofmupirocin, biofilmswere treated for 24 h at 37 C,
followedbyawashing stepwithphysiological saline. The sessile cellswere
harvested by 2 rounds of 5min vortexing (900 rpm, Titramax 1000, Hei-
dolph Instruments, Schwabach, Germany) and 5min sonication (Branson
3510, Branson Ultrasonics Corp., Danbury, CT, USA). Next, the effect of
the treatments was evaluated by plate counting.
Biofilm disruption procedure
Disruption of 24 h-old biofilms was done by washing the sessile cells
with physiological saline followed by 2 rounds of 5min vortexing and
5min sonication. Next, the disrupted cells were treated with 2.67x
concentrated solutions of the antimicrobial agents (taking into account
the dilution factor introduced by the disruption procedure) as described
in Table 1. After neutralization with DENB, the number of CFU/biofilm
per condition was determined by plating.
Statistical analysis
SPSS Statistics 24 (SPSS, Chicago, IL, USA) was used to analyze the7
data. To assess the normality of the data sets, the Shapiro–Wilk test was
used. The one-way analysis of variance test and independent samples T-
test were used for normally distributed data. The Kruskal–Wallis test and
Mann–Whitney U test were used for non-normally distributed data. Dif-
ferences with a p-value < 0.05 were considered significant.
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